ES2369717T3 - Estabilización de conjugados que comprenden una molécula conectora de tiourea. - Google Patents

Estabilización de conjugados que comprenden una molécula conectora de tiourea. Download PDF

Info

Publication number
ES2369717T3
ES2369717T3 ES08020499T ES08020499T ES2369717T3 ES 2369717 T3 ES2369717 T3 ES 2369717T3 ES 08020499 T ES08020499 T ES 08020499T ES 08020499 T ES08020499 T ES 08020499T ES 2369717 T3 ES2369717 T3 ES 2369717T3
Authority
ES
Spain
Prior art keywords
thiourea
conjugate
derivative
group
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08020499T
Other languages
English (en)
Spanish (es)
Inventor
Rene Blind
Gerhard Fink
Eva Hoess
Hans-Joachim Kytzia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Original Assignee
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG, Roche Diagnostics GmbH filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2369717T3 publication Critical patent/ES2369717T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES08020499T 2007-11-30 2008-11-26 Estabilización de conjugados que comprenden una molécula conectora de tiourea. Active ES2369717T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07023206 2007-11-30
EP07023206 2007-11-30

Publications (1)

Publication Number Publication Date
ES2369717T3 true ES2369717T3 (es) 2011-12-05

Family

ID=39271113

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08020499T Active ES2369717T3 (es) 2007-11-30 2008-11-26 Estabilización de conjugados que comprenden una molécula conectora de tiourea.

Country Status (7)

Country Link
US (1) US20110112291A1 (cg-RX-API-DMAC7.html)
EP (1) EP2065705B1 (cg-RX-API-DMAC7.html)
JP (1) JP5523695B2 (cg-RX-API-DMAC7.html)
CN (1) CN101445503A (cg-RX-API-DMAC7.html)
AT (1) ATE518138T1 (cg-RX-API-DMAC7.html)
CA (1) CA2645309C (cg-RX-API-DMAC7.html)
ES (1) ES2369717T3 (cg-RX-API-DMAC7.html)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5112930A (en) * 1975-04-08 1976-01-31 Kumiai Chemical Industry Co Anteiseiryokonaru noengeiyosakinsoseibutsu
JPS5718605A (en) * 1980-07-07 1982-01-30 Kumiai Chem Ind Co Ltd Stable insecticidal composition
GB2095818B (en) 1981-03-27 1985-10-02 Exxon Research Engineering Co Staged adsorption/resorption heat pump
JPS5855417A (ja) * 1981-09-27 1983-04-01 Nitto Electric Ind Co Ltd 医薬組成物
AU2541592A (en) * 1991-08-01 1993-03-02 Hybritech Incorporated Improvements in or relating to modified haptens useful as imaging and therapeutic agents
US5541287A (en) * 1992-06-09 1996-07-30 Neorx Corporation Pretargeting methods and compounds
WO1995006877A1 (en) * 1993-09-03 1995-03-09 Behringwerke Ag Fluorescent oxygen channeling immunoassays
IT1298693B1 (it) * 1996-04-24 2000-01-12 Hoffmann La Roche Derivati della fluoresceina 4'-metil sostituiti
EP1179541B1 (en) * 1999-04-28 2004-06-16 Board Of Regents, The University Of Texas System Compositions and methods for cancer treatment by selectively inhibiting VEGF
US6586628B2 (en) * 2000-05-10 2003-07-01 The United States Of America, As Represented By The Secretary Of Agriculture 3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same
US6586460B1 (en) 2001-04-02 2003-07-01 The Board Of Regents For Oklahoma State University Heteroarotinoids containing urea or thiourea linker
US20030171260A1 (en) * 2002-03-11 2003-09-11 Nelson Deanna Jean Compositions and methods utilizing hydroxamates to scavenge oxidant toxins
US7371524B2 (en) * 2003-06-17 2008-05-13 Hannjorg Hereth Substituted azaporphyrins as fluorescence labels
DE102004045748A1 (de) * 2004-09-21 2006-04-06 Roche Diagnostics Gmbh Stöchiometrisch definierte farbstoffmarkierte Substanzen zur Messung der glomerulären Filtrationsrate, ihre Herstellung und Verwendung
EP1795607A1 (en) * 2005-12-08 2007-06-13 Roche Diagnostics GmbH Stabilized cholinesterase substrate solution
NZ548931A (en) * 2006-05-15 2008-03-28 Wyeth Corp Stabilised formulation of moxidectin

Also Published As

Publication number Publication date
EP2065705A1 (en) 2009-06-03
JP5523695B2 (ja) 2014-06-18
CA2645309C (en) 2016-07-19
CA2645309A1 (en) 2009-05-30
JP2009132716A (ja) 2009-06-18
EP2065705B1 (en) 2011-07-27
US20110112291A1 (en) 2011-05-12
ATE518138T1 (de) 2011-08-15
CN101445503A (zh) 2009-06-03

Similar Documents

Publication Publication Date Title
ES2926662T3 (es) Anticuerpos contra haptenos de risperidona y uso de los mismos
ES2665953T3 (es) Inmunoensayos que emplean reactivos quimioluminiscentes no particulados
ES2712487T3 (es) Estabilización de reactivos de ensayo en soporte sólido
ES2486815T3 (es) Marcadores de éster de acridinio que tienen modificadores hidrófilos
US5952187A (en) Topiramate immunoassay
ES2474154T3 (es) Detección de drogas
ES2881305T3 (es) Diseño de ensayo sandwich para pequeñas moléculas
ES2673557T3 (es) Ensayo de tipo sándwich para fármacos inmunodepresores
US10114030B2 (en) Detection agent for detecting 25-hydroxy vitamin D, preparation method and use
ES2863624T3 (es) Ensayo en sándwich para moléculas pequeñas
ES2250972T3 (es) Inmunoensayo para acido micofenolico.
US10241116B2 (en) Dual-sensitizer-containing luminescent compounds, conjugates, and uses thereof
ES2701233T3 (es) Derivados de folato, particularmente útiles en el marco de la dosificación de folatos(s)
ES2371801T3 (es) Uso de derivados de fenobarbital en inmunoensayos.
ES2936294T3 (es) Inmunoensayo homogéneo con compensación para señal de fondo
JPS60133367A (ja) リドカインおよびその類縁体のための免疫原
US4136159A (en) Radioassay of folates
ES2398042T3 (es) Kit y procedimiento para el marcaje de biomoléculas
CA2645309C (en) Stabilization of conjugates comprising a thiourea linker
ES2360699T3 (es) Inmunoensayo basado en la inhibición enzimática.
ES2747634T3 (es) Formulaciones líquidas estabilizadas que contienen receptores
HK1132997A (en) Stabilization of conjugates comprising a thiourea linker
US5696264A (en) Folate-alp conjugate
US5543311A (en) Labeled carbamazepine hapten analogues for competitive enzyme immunoassays
ES2898125B2 (es) Bioconjugados heterologos y su uso para la inmunodeteccion de aflatoxinas